Back in the old days, scientists from around the world are keeping their discoveries in private notes, and they keep them in their library. It is up to them whether they would like to publish their discovery, but it will take years before the information reached other cities around the globe. With the introduction of the internet, data can be transported on the other side of the planet in an instant. Scientists, oncologists, in particular, have been dreaming of a platform for years that can store data and information, and be shared with other scientists around the world. It has been thought as an impossible feat until two oncologists from the Roswell Park Cancer Institute found out a way to address this issue. Listen to Oncotarget podcast on Player.FM.
Dr. Mikhail Blagosklonny and Andrei V. Gurkov are oncologists working at the Roswell Park Cancer Institute either as a professor, a researcher, or a scientist. They have spent so many years in studying cancer and finding out how it can be eradicated. They have been sharing their information regularly with other scientists around the world who decided to be their partners with cancer research, but the data shared is not organized and can be lost anytime. Because of the necessity to store the data and information and then transfer them safely, later on, Dr. Mikhail Blagosklonny and Andrei V. Gurkov thought of migrating the data and information that they formulated on a large, online portal that can be accessed by anyone. The idea became a reality in 2010 when they launched Oncotarget.
Since its introduction, Oncotarget quickly became the most popular online medical journal, being used by a lot of scientists around the world. They are grateful to the innovation that was made by Dr. Mikhail Blagosklonny and Mr. Gurkov, and the scientists have stated that the new online medical journal can save lives, as well as time and money. What the scientists do is that they check the portal every time for original articles, and after they found one, they are discussing it with their colleagues and try out several experimentation to see if it works.
Oncotarget has been a favorite among scientists, and they keep on putting new information on the portal. Oncotarget would later publish this information online and makes it possible for other scientists around the world to get their copy of the report and leave a review based on what they think about the publication. Check Oncotarget journal at scimagojr.com